Quality criteria on the implementation of transcatheter aortic valve implantation (TAVI): Position paper of the German Society of Cardiology;Qualitätskriterien zur Durchführung der transvaskulären Aortenklappenimplantation (TAVI): Positionspapier der Deutschen Gesellschaft für Kardiologie

Kardiologe

Volumn 9, Issue 1, 2015, Pages 11-26

  Kuck, K H ^a   Eggebrecht, H ^b   Figulla, H R ^c   Haude, M ^d   Katus, H ^e   Mollmann H ^f   Naber, C K ^g   Schunkert, H ^h   Thiele, H ⁱ   Hamm, C ^j  

^a DEPARTMENT OF CARDIOLOGY   (Germany)

^b CARDIOANGIOLOGISCHES CENTRUM BETHANIEN   (Germany)

^c JENA UNIVERSITY HOSPITAL   (Germany)

^d Lukaskrankenhaus GmbH   (Germany)

^e UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^f KERCKHOFF HEART CENTER   (Germany)

^g ELISABETH KRANKENHAUS ESSEN   (Germany)

^h TECHNICAL UNIVERSITY OF MUNICH   (Germany)

ⁱ UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^j UNIVERSITY HOSPITAL GIESSEN   (Germany)

more..

Author keywords

Centers; Certification; Indications; Treatment

Indexed keywords

ANESTHESIST; AORTA VALVE REPLACEMENT; AORTA VALVE STENOSIS; ARTICLE; BIOPROSTHESIS; CARDIAC SURGEON; CARDIOLOGY; COMPUTER ASSISTED TOMOGRAPHY; ELECTROCARDIOGRAPHY MONITORING; EUROSCORE; HEALTH CARE PERSONNEL; HEART CATHETER; HEART SURGERY; HIGH RISK PATIENT; HUMAN; INTENSIVE CARE UNIT; LIFE EXPECTANCY; MEDICAL SOCIETY; MEDICAL SPECIALIST; MORBIDITY; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; OPERATING ROOM; PATIENT CARE; PATIENT COUNSELING; PATIENT EDUCATION; PERCUTANEOUS CORONARY INTERVENTION; QUALITY CONTROL; RISK ASSESSMENT; STANDARD; SURGICAL RISK; TRANSCATHETER AORTIC VALVE IMPLANTATION; VALVULOPLASTY;

EID: 84925488550     PISSN: 18649718     EISSN: 18649726     Source Type: Journal    
DOI: 10.1007/s12181-014-0622-8     Document Type: Article

References (60)

1. Nkomo VT, Gardin JM, Skelton TN et al (2006) Burden of valvular heart diseases: a population-based study. Lancet 368:1005–1011
2. Ross J Jr, Braunwald E (1968) Aortic stenosis. Circulation 38:61–67
3. Eltchaninoff H, Nusimovici-Avadis D, Babaliaros V et al (2006) Five month study of percutaneous heart valves in the systemic circulation of sheep using a novel model of aortic insufficiency. EuroIntervention 1:438–444
4. Cribier A, Eltchaninoff H, Bash A et al (2002) Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 106:3006–3008
5. Ferrari M, Figulla HR, Schlosser M et al (2004) Transarterial aortic valve replacement with a self expanding stent in pigs. Heart 90:1326–1331
6. Buellesfeld L, Gerckens U, Grube E (2008) Percutaneous implantation of the first repositionable aortic valve prosthesis in a patient with severe aortic stenosis. Catheter Cardiovasc Interv 71(5):579–584
7. Iung B, Baron G, Butchart EG et al (2003) A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on valvular heart disease. Eur Heart J 24:1231–1243
8. Leon MB, Smith CR, Mack M et al (2010) Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 363:1597–1607
9. Kapadia SR, Tuzcu EM, Makkar RR et al (2014) Long-term outcomes of inoperable patients with aortic stenosis randomized to transcatheter aortic valve replacement or standard therapy. Circulation 130:1483–1492
10. Smith CR, Leon MB, Mack MJ et al (2011) Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 364:2187–2198
11. Adams DH, Popma JJ, Reardon MJ et al (2014) Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med 370:1790–1798
12. Seiffert M, Diemert P, Koschyk D et al (2013) Transapical implantation of a second-generation transcatheter heart valve in patients with noncalcified aortic regurgitation. JACC Cardiovasc Interv 6:590–597
13. Roy DA, Schaefer U, Guetta V et al (2013) Transcatheter aortic valve implantation for pure severe native aortic valve regurgitation. J Am Coll Cardiol 61:1577–1584
14. Eggebrecht H, Schäfer U, Treede H et al (2011) Valve-in-valve transcatheter aortic valve implantation for degenerated bioprosthetic heart valves. JACC Cardiovasc Interv 4(11):1218–1227
15. Figulla HR, Cremer J, Walther T et al (2009) Positionspapier zur kathetergeführten Aortenklappenintervention. Kardiologe 3:199–206
16. Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC), European Association for Cardio-Thoracic Surgery (EACTS), Vahanian A et al (2012) Guidelines on the management of valvular heart disease (version 2012). Eur Heart J 33:2451–2496
17. Hamm CW, Möllmann H, Holzhey D et al (2014) The German Aortic Valve Registry (GARY): in-hospital outcome. Eur Heart J 35:1588–1598
18. Kodali SK, Williams MR, Smith CR et al (2012) Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med 366(18):1686–1695
19. Abdel-Wahab M, Mehilli J, Frerker C et al (2014) Comparison of balloon-expandable vs. self-expandable valves in patients undergoing transcatheter aortic valve replacement: the CHOICE randomized clinical trial. JAMA 311:1503–1514
20. Zahn R, Gerckens U, Grube E et al (2011) Transcatheter aortic valve implantation: first results from a multi-centre real-world registry. Eur Heart J 32(2):198–204
21. Sherif MA, Zahn R, Gerckens U et al (2014) Effect of gender differences on 1-year mortality after transcatheter aortic valve implantation for severe aortic stenosis: results from a multicenter real-world registry. Clin Res Cardiol 103(8):613–620
22. Mohr FW, Holzhey D, Möllmann H et al (2014) The German Aortic Valve Registry: 1-year results from 13680 patients with aortic valve disease. Eur J Cardiothorac Surg 46:808–816
23. Rosenhek R, Iung B, Tornos P et al (2012) ESC Working Group on Valvular Heart Disease Position Paper: assessing the risk of interventions in patients with valvular heart disease. Eur Heart J 33:822–828
24. Seiffert M, Sinning JM, Meyer A et al (2014) Development of a risk score for outcome after transcatheter aortic valve implantation. Clin Res Cardiol 103(8):631–640
25. Sündermann S, Dademasch A, Praetorius J et al (2011) Comprehensive assessment of frailty for elderly high-risk patients undergoing cardiac surgery. Eur J Cardiothorac Surg 39:33–37
26. Kötting J, Schiller W, Beckmann A et al (2013) German Aortic Valve Score: a new scoring system for prediction of mortality related to aortic valve procedures in adults. Eur J Cardiothorac Surg 43(5):971–977
27. Sinning JM, Vasa-Nicotera M, Chin D et al (2013) Evaluation and management of paravalvular aortic regurgitation after transcatheter aortic valve replacement. J Am Coll Cardiol 62:11–20
28. Martinez-Selles M, Bramlage P, Thoenes M, Schymik G (2014) Clinical significance of conduction disturbances after aortic valve intervention: current evidence. Clin Res Cardiol [Epub ahead of print]
29. Siontis GC, Jüni P, Pilgrim T et al (2014) Predictors of permanent pacemaker implantation in patients with severe aortic stenosis undergoing TAVR: a meta-analysis. J Am Coll Cardiol 64:129–140
30. Khatri PJ, Webb JG, Rodés-Cabau J et al (2013) Adverse effects associated with transcatheter aortic valve implantation: a meta-analysis of contemporary studies. Ann Intern Med 158:35–46
31. Erkapic D, De Rosa S, Kelava A et al (2012) Risk for permanent pacemaker after transcatheter aortic valve implantation: a comprehensive analysis of the literature. J Cardiovasc Electrophysiol 23:391–397
32. Webb JG (o J) 30-day outcomes from the SAPIEN 3 trial. http://www.pcronline.com/Lectures/2014/30-day-outcomes-from-the-SAPIEN-3-trial
33. Eggebrecht H, Schmermund A, Voigtländer T et al (2012) Risk of stroke after transcatheter aortic valve implantation (TAVI): a meta-analysis of 10,037 published patients. EuroIntervention 8:129–138
34. Linke A (2014) Clean-TAVI. Late Breaking Clinical Trial Session, TCT
35. Gilard M, Eltchaninoff H, Iung B et al (2012) Registry of transcatheter aortic-valve implantation in high-risk patients. N Engl J Med 366:1705–1715
36. Mack MJ, Brennan JM, Brindis R et al (2013) Outcomes following transcatheter aortic valve replacement in the United States. JAMA 310:2069–2077
37. Eggebrecht H, Schmermund A, Kahlert P et al (2013) Emergent cardiac surgery during transcatheter aortic valve implantation (TAVI): a weighted meta-analysis of 9,251 patients from 46 studies. EuroIntervention 8:1072–1080
38. Hein R, Abdel-Wahab M, Sievert H et al (2013) Outcome of patients after emergency conversion from transcatheter aortic valve implantation to surgery. EuroIntervention 9:446–451
39. Griese DP, Reents W, Kerber S et al (2013) Emergency cardiac surgery during transfemoral and transapical transcatheter aortic valve implantation: incidence, reasons, management, and outcome of 411 patients from a single center. Catheter Cardiovasc Interv 82:E726–E733
40. Walther T, Möllmann H, Mudra H et al (2014) Incidence of procedural complications in 9271 consecutive TAVI patients: analysis from the German Aortic Valve Registry (GARY). J Am Coll Cardiol 63(12_S). doi:10.1016/S0735-1097(14)61945-8 (Abstract)
41. Schymik G, Heimeshoff M, Bramlage P et al (2014) Ruptures of the device landing zone in patients undergoing transcatheter aortic valve implantation: an analysis of TAVI Karlsruhe (TAVIK) patients. Clin Res Cardiol 103:912–920
42. Blanke P, Reinöhl J, Schlensak C et al (2012) Prosthesis oversizing in balloon-expandable transcatheter aortic valve implantation is associated with contained rupture of the aortic root. Circ Cardiovasc Interv 5:540–548
43. Pasic M, Unbehaun A, Dreysse S et al (2012) Rupture of the device landing zone during transcatheter aortic valve implantation: a life-threatening but treatable complication. Circ Cardiovasc Interv 5:424–432
44. Barbanti M, Yang TH, Rodès Cabau J et al (2013) Anatomical and procedural features associated with aortic root rupture during balloon-expandable transcatheter aortic valve replacement. Circulation 128:244–253
45. Eggebrecht H, Mehta RH, Kahlert P et al (2013) Emergent cardiac surgery during transcatheter aortic valve implantation (TAVI): insights from the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry. EuroIntervention. pii:20130924-01 [Epub ahead of print]
46. Ribeiro HB, Webb JG, Makkar RR et al (2013) Predictive factors, management, and clinical outcomes of coronary obstruction following transcatheter aortic valve implantation: insights from a large multicenter registry. J Am Coll Cardiol 62:1552–1562
47. Geisbüsch S, Bleiziffer S, Mazzitelli D et al (2010) Incidence and management of CoreValve dislocation during transcatheter aortic valve implantation. Circ Cardiovasc Interv 3:531–536
48. Kappetein AP, Head SJ, Généreux P et al (2012) Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. Eur Heart J 33:2403–2418
49. Bagur R, Webb JG, Nietlispach F et al (2010) Acute kidney injury following transcatheter aortic valve implantation: predictive factors, prognostic value, and comparison with surgical aortic valve replacement. Eur Heart J 31:865–874
50. Barbanti M, Latib A, Sgroi C et al (2014) Acute kidney injury after transcatheter aortic valve implantation with self-expanding CoreValve prosthesis: results from a large multicentre Italian research project. EuroIntervention 10:133–140
51. Barbash IM, Ben-Dor I, Dvir D et al (2012) Incidence and predictors of acute kidney injury after transcatheter aortic valve replacement. Am Heart J 163:1031–1036
52. Zhang Y, Pyxaras S, Wolf A et al (2014) Propensity-matched comparison between Direct Flow Medical, Medtronic Corevalve and Edwards Sapien XT prostheses: device success, thirty-day safety and mortality; EuroPCR (Abstract)
53. Nishimura RA, Otto CM, Bonow RO et al (2014) 2014 AHA/ACC Guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 63:2438–2488
54. Tommaso CL, Bolman RM III, Feldman T et al (2012) Multisociety (AATS, ACCF, SCAI, and STS) expert consensus statement: operator and institutional requirements for transcatheter valve repair and replacement, part 1: transcatheter aortic valve replacement. J Thorac Cardiovasc Surg 143:1254–1263
55. Holmes DR Jr, Mack MJ, Kaul S et al (2012) 2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement. J Am Coll Cardiol 59:1200–1254
56. Schächinger V, Nef H, Achenbach S et al (2014) Leitlinie zum Einrichten und Betreiben von Herzkatheterlaboren und Hybrid-Operationssälen/Hybrid-Laboren, 3. Aufl. (im Druck)
57. http://leitlinien.dgk.org/files/2008_Leitlinie_Diagnostische_Herzkatheteruntersuchung.pdf
58. http://leitlinien.dgk.org/files/2001_Leitlinie_Einrichtung_und_Betreiben_von_Herzkatheterraeumen.pdf
59. http://www.beuth.de/de/norm/din-1946-4/111137028
60. http://www.vdi.de/technik/fachthemen/bauen-und-gebaeudetechnik/fachbereiche/technischegebaeudeausruestung/richtlinienarbeit/richtlinienreihe-vdi-6022-raumlufttechnik-raumluftqualitaet/